310 related articles for article (PubMed ID: 16917914)
1. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
[TBL] [Abstract][Full Text] [Related]
2. Fibrinogen fragments and platelet dysfunction in uremia.
Kozek-Langenecker SA; Masaki T; Mohammad H; Green W; Mohammad SF; Cheung AK
Kidney Int; 1999 Jul; 56(1):299-305. PubMed ID: 10411706
[TBL] [Abstract][Full Text] [Related]
3. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors.
Sreedhara R; Itagaki I; Hakim RM
Am J Kidney Dis; 1996 Mar; 27(3):355-64. PubMed ID: 8604704
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of platelet surface glycoprotein receptor IIb/IIIa at hyperthermic temperatures.
Pasha R; Benavides M; Kottke-Marchant K; Harasaki H
Lab Invest; 1995 Sep; 73(3):403-8. PubMed ID: 7564273
[TBL] [Abstract][Full Text] [Related]
5. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
[TBL] [Abstract][Full Text] [Related]
6. Expression of fibrinogen receptors on platelets of uremic patients is correlated with the content of GPIIb and plasma level of creatinine.
Walkowiak B; Pawlowska Z; Michalak E; Cierniewski CS
Thromb Haemost; 1994 Feb; 71(2):164-8. PubMed ID: 8191392
[TBL] [Abstract][Full Text] [Related]
7. [Effect of danshen injection on expression of platelet membrane glycoproteins in patients with type II diabetes mellitus].
Zhang M; Li X; Jiu G; Liu Y
Zhong Yao Cai; 2003 Oct; 26(10):738-40. PubMed ID: 14768394
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein specifically binds glycoprotein IIb/IIIa: a flow cytometric method for ligand-receptor interaction.
Tetik S; Uras F; Ekşioğlu-Demiralp E; Turay Yardimci K
Clin Appl Thromb Hemost; 2008 Apr; 14(2):210-9. PubMed ID: 18160616
[TBL] [Abstract][Full Text] [Related]
10. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
11. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
[TBL] [Abstract][Full Text] [Related]
12. Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia.
Benigni A; Boccardo P; Galbusera M; Monteagudo J; De Marco L; Remuzzi G; Ruggeri ZM
Am J Kidney Dis; 1993 Nov; 22(5):668-76. PubMed ID: 8238012
[TBL] [Abstract][Full Text] [Related]
13. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
Chiang TM; Zhu J
Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
Salvati F; Liani M
Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Interactions of platelets with Synthocytes, a novel platelet substitute.
Davies AR; Judge HM; May JA; Glenn JR; Heptinstall S
Platelets; 2002 Jun; 13(4):197-205. PubMed ID: 12189020
[TBL] [Abstract][Full Text] [Related]
17. [Platelets and platelet microparticles glycoprotein IIb/IIIa complex in patients with unstable angina].
Dymicka-Piekarska V; Kemona H; Butkiewicz A; Bychowski J
Pol Merkur Lekarski; 2005 Jan; 18(103):9-12. PubMed ID: 15859538
[TBL] [Abstract][Full Text] [Related]
18. [Quality control of stored platelet concentrates by means of flow cytometry].
Böck M; Gawaz M; Heim MU; Mempel W
Beitr Infusionsther Transfusionsmed; 1994; 32():397-400. PubMed ID: 9480132
[TBL] [Abstract][Full Text] [Related]
19. [Variant of Paris-I Lariboisière thrombasthenia, a molecular anomaly of the IIb-IIIa platelet glycoprotein complex].
Caen JP; Rosa JP; Soria C; Boizard B
C R Seances Acad Sci III; 1983; 296(10):479-81. PubMed ID: 6223690
[TBL] [Abstract][Full Text] [Related]
20. Studies of fibrinogen binding to porcine platelets by flow cytometry: a method for studies of porcine platelet activation.
Larsson A; Eriksson M; Lindahl TL
Platelets; 2002 May; 13(3):153-7. PubMed ID: 12180497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
